Clinical Immunization Safety Assessment 2023 - 2028 (CISA)

Active Master IDIQ Awarded

Federal agency
Awardees
8
Task orders
22
Obligated
$24,595,163

Vehicle facts

Opportunity
Agency
  • CDC Pittsburgh Centers for Disease Control and Prevention, Department of Health and Human Services
Combined task order value
  • $24,638,088 Current, with exercised options
  • $27,410,040 Potential, with all options
Last date to order 62% complete
Shared ceiling 29% used
$86,008,000.12

IDV award and task order details come from SAM.gov/FPDS.

About this vehicle

The CDC's National Center for Emerging and Zoonotic Infectious Diseases awarded the Clinical Immunization Safety Assessment 2023–2028 Master IDIQ on September 26, 2023, with a shared ceiling of $86 million and ordering authority extending to September 21, 2028. The vehicle is unrestricted and competitive; all 17 task orders to date carry no set-aside designation.

Ordering activity has declined materially since launch. The contracting office issued 12 task orders in 2023 and 5 in 2024; the most recent award was September 27, 2024, roughly 21 months ago. The combined task-order potential value stands at $21.8 million, with $16.7 million (76%) already obligated, leaving approximately $4.1 million unobligated across the portfolio and $64.2 million unallocated from the shared ceiling.

The vehicle funds clinical case reviews and evaluation of vaccine safety issues, clinical vaccine safety evaluation, and research studies to advance vaccine safety knowledge and inform clinical and public health practice. Awardees must be medical research centers that provide clinical care and can recruit research participants. All task orders are cost-no-fee pricing with durations ranging from three to five years.

Competition is concentrated among academic medical centers and children's hospitals. Vanderbilt University Medical Center leads by potential value with a single order worth $6.6 million. Duke University, Emory University, and Children's Hospital Medical Center each hold three orders; these four institutions account for 86% of combined task-order potential value. Boston Medical Center Corporation and Columbia University round out the active prime base, with a wider field of academic health systems appearing in earlier awards. The CDC Pittsburgh Immunization Safety Office is the sole funding customer across all 17 orders.

Task-order ceilings range from approximately $240,000 to $6.6 million, with typical awards in the $700,000 to $2.2 million band. Recent 2024 awards target an RSV Infants Study across multiple lead and contributing sites, with completion scheduled for September 26, 2027.

IDV awards

Latest task orders

Task order Awardee Awarding agency Obligated Last action
Cisa home laiv study - contributing site EO 14398 75D30126F00003 Boston Medical Center Corporation CDC Pittsburgh $784,899
Home cisa laiv study - contributing site EO 14398 75D30126F00003 Kaiser Foundation Hospitals CDC Pittsburgh $981,237
Cisa home laiv study contributing site - EO 14398 75D30126F00004 Emory University CDC Pittsburgh $910,875
Cisa home laiv study- lead site, EO 14398 75D30126F00004 Duke University CDC Pittsburgh $1,869,870
(cisa) home laiv study - contributing site, EO 14398 75D30126F00002 Vanderbilt University Medical Center CDC Pittsburgh $912,944
2023 clinical immunization safety assessment (cisa) base IDIQ 75D30123F00001 Childrens Hospital Medical Center CDC Pittsburgh $894,604
2023 clinical immunization safety assessment (cisa) base IDIQ 75D30123F00001 Kaiser Foundation Hospitals CDC Pittsburgh $178,676
2023 clinical immunization safety assessment (cisa) base IDIQ 75D30123F00001 Duke University CDC Pittsburgh $730,242
2023 clinical immunization safety assessment (cisa) base IDIQ 75D30123F00001 Boston Medical Center Corporation CDC Pittsburgh $855,741
2023 clinical immunization safety assessment (cisa) base IDIQ 75D30123F00001 The Trustees Of Columbia University In The City Of New York CDC Pittsburgh $224,674
2023 clinical immunization safety assessment (cisa) base IDIQ 75D30123F00001 Vanderbilt University Medical Center CDC Pittsburgh $5,279,183
2023 clinical immunization safety assessment (cisa) base IDIQ 75D30123F00001 Emory University CDC Pittsburgh $763,380
2023 clinical immunzation safety assessment (cisa) base IDIQ 75D30123F00001 The Johns Hopkins University CDC Pittsburgh $752,113
2023 clinical immunization safety assessment (cisa) base IDIQ 75D30123F00002 Duke University CDC Pittsburgh $2,171,300
Cisa RSV infants study (lead site) 75D30124F00003 Childrens Hospital Medical Center CDC Pittsburgh $709,088
Cisa RSV infants study (lead site) 75D30124F00003 Duke University CDC Pittsburgh $1,532,778
Cisa RSV infants study (contributing site) 75D30124F00003 Emory University CDC Pittsburgh $774,481
Cisa RSV infants study (contributing site) 75D30124F00002 Kaiser Foundation Hospitals CDC Pittsburgh $730,098
Cisa RSV infants study (contributing site) 75D30124F00002 The Trustees Of Columbia University In The City Of New York CDC Pittsburgh $767,661
2023 clinical immunization safety assessment (cisa) base IDIQ 75D30123F00002 Childrens Hospital Medical Center CDC Pittsburgh $896,534
2023 clinical immunization safety assessment (cisa) base IDIQ 75D30123F00002 Emory University CDC Pittsburgh $966,702
2023 clinical immunization safety assessment (cisa) base IDIQ 75D30123F00002 Boston Medical Center Corporation CDC Pittsburgh $908,084
Show all 22

Top awardees by obligations

Rank Awardee Obligated Share
1 Duke University $6,304,190 26%
2 Vanderbilt University Medical Center $6,192,127 25%
3 Emory University $3,415,438 14%
4 Boston Medical Center Corporation $2,548,724 10%
5 Childrens Hospital Medical Center $2,500,226 10%
6 Kaiser Foundation Hospitals $1,890,011 8%
7 The Trustees Of Columbia University In The City Of New York $992,335 4%
8 The Johns Hopkins University $752,113 3%

Top funding agencies by obligations

Rank Funding agency Obligated Share
1 Department of Health and Human Services $24,595,163 100%

Obligations by fiscal year

Fiscal year Obligated
FY2026 $7,928,280
FY2025 $2,411,459
FY2024 $6,928,194
FY2023 $7,327,231

Quick answers

What is the CISA contract vehicle?

Clinical Immunization Safety Assessment 2023 - 2028 (CISA) is an indefinite delivery, indefinite quantity (IDIQ) contract vehicle run by CDC Pittsburgh (Centers for Disease Control and Prevention), awarded on September 26, 2023.

Which companies hold CISA?

8 companies hold CISA's IDV awards, one each. The latest went to Kaiser Foundation Hospitals on September 27, 2023. The awardees whose task orders obligated the most are Duke University, Vanderbilt University Medical Center and Emory University.

How much has been spent through CISA?

22 task orders have been placed under CISA, obligating $24,595,163. Their combined current value, with exercised options, is $24,638,088.

What is the shared ceiling of CISA?

CISA's shared ceiling is $86,008,000; its task orders have used 29% of it.

Which agencies use CISA the most?

The departments whose task orders under CISA obligated the most are Department of Health and Human Services ($24,595,163).

How much was obligated through CISA in fiscal year 2025?

Task orders under CISA obligated $2,411,459 in fiscal year 2025.

On GovTribe

See this vehicle's full record

  • Every IDV award and task order
  • Funding by agency, awardee, NAICS and set-aside
  • Teaming partners on this vehicle
  • Ask GovTribe AI about this vehicle